Related Experiment Video
Updated: Jun 24, 2026
09:29
Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy
Published on: August 17, 2021
Commentary: the prospect of cell-based therapy for epilepsy
Arnold R Kriegstein1, Asla Pitkänen
1Department of Neurology, University of California, San Francisco, California 94143-0525, USA. kriegsteina@stemcell.ucsf.edu
Summary
Cell-based therapies offer new hope for epilepsy treatment, particularly for the 30% of patients unresponsive to current drugs. These therapies aim to repair brain circuits and produce natural anticonvulsants to manage epilepsy effectively.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Epilepsy Research
Background:
- Approximately 30% of epilepsy patients exhibit drug resistance to existing antiepileptic drugs.
- Novel therapeutic strategies are crucial for preventing or mitigating the epileptogenic process following brain injuries.
- Cell transplantation presents a promising avenue for epilepsy treatment.
Discussion:
- Cell transplants can function as "factories" producing endogenous anticonvulsants.
- They can also act as "bricks" to repair abnormal neuronal circuits involved in ictogenesis and epileptogenesis.
- Cell-based therapies represent a potential novel therapeutic category for epilepsy management.
Key Insights:
- Cell-based therapies offer a dual approach: anticonvulsant production and neuronal circuit repair.
- This strategy addresses the unmet need for effective treatments in drug-resistant epilepsy.
- The potential for endogenous anticonvulsant production by transplanted cells is a significant advantage.
Outlook:
- Further research is needed to optimize cell transplantation protocols for epilepsy.
- Clinical translation of cell-based therapies holds promise for improved patient outcomes.
- Exploring the long-term efficacy and safety of these regenerative approaches is essential.
More Related Videos
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
00:57Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...